A Mutated Prostatic Acid Phosphatase (PAP) Peptide-Based Vaccine Induces PAP-Specific CD8+ T Cells with Ex Vivo Cytotoxic Capacities in HHDII/DR1 Transgenic Mice.
Cancers (Basel)
; 14(8)2022 Apr 13.
Article
in En
| MEDLINE
| ID: mdl-35454873
ABSTRACT